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Abstract: 
Purpose: Osteoarthritis (OA) presents as a change in the chondrocyte phenotype and an imbalance 
between anabolic and catabolic processes. Factors such age affect onset and progression. Classically 
small nucleolar RNAs (snoRNAs) direct chemical modification of RNA substrates and enable 
endoribonucleolytic pre-rRNA processing. However, characterization of diverse non-canonical 
snoRNA functions are increasingly becoming elucidated; regulation of chromatin structure, 
mediators of oxidative stress and microRNA-like functions. The loss of two gene clusters encoding 
the non-canonical snoRNAs SNORD115 and SNORD116 causes Prader-Willi syndrome (PWS). They 
are also involved in alternative splicing of specific target genes. These orphan snoRNAs do not target 
RNA substrates. PWS is characterized by hyperphagia, short stature, hormonal imbalances and 
reduced muscle mass. Additionally diminished bone mineral density and osteoporosis are common 
at a young age. Snord 116 knockout mice show reduced bone formation indicating a link between 
the PW critical region and osteoporosis. Overexpression or knockdown (PWS) of SNORD116 in HEK 
cells changed the expression of 200 mRNA genes, whilst in the hypothalamus from PWS versus 
normal patients 12 gene expression levels were validated as influenced by SNORD116. We have 
previously identified, following transcriptomic analysis of cartilage, a reduction in SNORD116 in OA 
and ageing. Therefore we hypothesize SNORD116 has a role in OA. 
Methods: Total RNA was extracted from cartilage following total knee arthroplasty from the medial 
(old normal; protected (P); n=10) and lateral (old OA; unprotected (U);n=10) femoral condyles from 
donors aged 62.6 ± 7.3 (mean ±standard deviation) years and the medial side of the lateral femoral 
condyle following anterior cruciate ligament repair surgery from young donors; 23.7 ± 3.8 years. 
Microarray analysis was undertaken using Affymetrix miRNA 4.0 arrays. Differentially expressed 
snoRNAs were defined with a FDR<0.05. OA severity was based on Kellgren and Lawrence scoring 
and histologically grading. Expression changes in SNORD116 were validated in an independent 
cohort (n=8 per condition) using qRT-PCR. Additionally qRT-PCR determined the effect of tissue 
culture conditions, mechanosensivity and passage on snord116 expression using equine 
chondrocytes and cartilage. Changes in expression of SNORD116 in OA chondrocytes and OA-like 
conditions were studied in chondrocytes using interleukin-1β (IL-1β) and healthy or OA synovial 
fluid. SNORD116 knockdown was undertaken in immature murine articular chondrocytes (iMACs) 
derived from a snord116Prx1Cre mouse line. IMACs derived from male pups (n=3 wild type; n=3 
snordprx1Cre) were exposed in triplicate technical replicates to IL-1β or TNFα for 24h and 
hypertrophic, chondrogenic and inflammatory gene expression measured using qRT-PCR. 
Results: Microarray results of cartilage identified an increase in SNORD116 in OA (P versus U; 
FDR<0.04) and a reduction in age (young versus U; FDR<0.04). These findings were validated in an 
independent cartilage cohort using qRT-PCR; p<0.03 and p<0.01 respectively. The expression of 
SNORD116 was not affected by oxygen tension, low serum or passage (up to P4) in chondrocyte 
culture conditions. Expression of snord116 was not dependent on the area of the joint the cartilage 
was taken from (high or low load areas). There was also an increase in SNORD116 in OA 
chondrocytes (p<0.04). SNORD116 expression responded to both OA and healthy synovial fluid 
(p<0.001, p<0.001 respectively). Similarly, catabolic provocation of chondrocytes by IL-1β increased 
SNORD116 levels in chondrocytes (p<0.04). IMAC experiments identified that there was an 
interaction between snord116 knockdown and response to cytokine stimulation on some 
chondrogenic, hypertrophic and inflammatory gene expression markers using a mixed effects linear 
regression model (Table 1 and 2). 
Conclusions: Interestingly we found SNORD116 expression was increased in OA but reduced in 
ageing cartilage. Furthermore, our iMAC work identified an interaction between snord116 
knockdown and expression of aggrecan, COL2A1, MMP3, IL6 and COL10 following IL-1β and MMP13, 
MMP3, COL10 and RUNX2 following TNFα treatments. Together with our other findings here, we 
believe SNORD116 has a role in the changing cartilage phenotype in OA through an unknown non-
canonical pathway. We used the ‘Skeletalvis’ online tool to interrogate the 12 genes previously 
identified as influenced by SNORD116. Of these seven were identified in previous studies as having 
roles in OA or response of chondrocytes or explants to IL-1β. We are currently using our transgenic 
mice to study the effect of SNORD116 knockdown on age-related OA and BMD using microCT. 
Table 1 
 
Table 2;statistical significance (p- values shown) 
TREATMENT GENE GENEOTYPE TNF INTERACTION 
TNF 24H AGGRECAN 0.03 0.000 0.12 
TNF 24H COL2A1 0.15 0.67 0.33 
TNF 24H SOX9 0.25 0.02 0.7 
TNF 24H MMP13 0.13 0.04 0.003 
TNF 24H MMP3 0.25 0.000 0.009 
TNF 24H COX2 0.7 0.43 0.09 
TNF 24H IL6 0.04 0.000 0.6 
TNF 24H COL10A1 0.23 0.11 0.000 
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